Phylogia licences technology to Janssen Biotech

Australian peptide drug discovery company Phylogica  has announced a collaboration and option agreement with pharmaceutical giant  Johnson & Johnson subsidiary Janssen Biotech Inc, to discover new classes of drugs derived from its Phylomer platform.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
10th-The University of Notre Dame Australia6,708
47 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer